Vijay Panikar JAPI JANUARY 2012 • VOL. 60
http://www.japi.org/january_2012/contents.html
Thursday, February 9, 2012
Pioglitazone and Ca Urinary Bladder
AFSSAPS French regulatory authority suspended the use of Pioglitazone in the treatment of Type 2 DM based on the reports of statistically significant increased risk of carcinoma urinary bladder. As India has large no. of Type 2DM patients, the treating doctors will have to review their prescription..
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment